Announcement on Progress in Litigation
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Progress in Litigation
Filed with SSE ·
Announcement on Progress in Litigation
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Chemclin Diagnostics Co., Ltd. on 6ix
Earlier from Chemclin Diagnostics
- Announcement on Implementation of Dividend Distribution for 2023
- Announcement on Resolutions of 2023 Annual General Meeting
- Announcement on Plan of Shareholding Reduction by Shareholders with Over 5% Shares
- Announcement on Attending Pharmaceutical Special Session of 2023 Annual Collective Performance Meeting of STAR Market and 2024 1st Quarter Performance Meeting
- Special Report on Storage and Use of Raised Funds in 2023
Later from Chemclin Diagnostics
- "Corporate Value and Return Enhancement" Action Plan 2024
- Announcement on Progress in Repurchasing Shares through Auction
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 5%
- Announcement on Resolution of the 10th Meeting of the 2nd Board of Supervisors
- Announcement on Participation in the 2024 Semi-annual Special Collective Performance Briefing for Medical Devices and Medical Equipment in STAR Market
Follow Chemclin Diagnostics into a list and get an email when it puts out news.
Follow Chemclin Diagnostics